Eligibility Criteria and Requirements

  • First-year students who have successfully completed CHEM 11 in the Fall term with above average academic performance
  • Student must show enthusiasm about conducting research
  • Project is clearly aligned with the student's academic trajectory
  • Student must be on campus and enrolled in classes throughout the term of research
  • Student engages in the research part-time during the academic term (estimated to be an average of 10 hrs/week during a 10-week academic term)
    • Student should maintain a record of time spent on the research and tasks accomplished
  • Student should discuss expectations with the faculty research mentor
  • Student may not receive FROiC funding for research associated with academic credit including independent study, thesis research, culminating projects, and projects for classes

Stipend Information

The student will receive a stipend of $1600 at the end of each completed term of research, contingent on confirmation by both the student and faculty research mentor. A one-page summary of the project and research accomplishments shall be submitted to the Department to release the second payment.

Applications

Applications are accepted in the Fall term for research in the following Winter and Spring Terms.  Eligible students will have successfully completed CHEM 11 in the Fall term with above average academic performance and will be notified of FROiC project opportunities by their CHEM 11 professor.

Applications are due the week before the end of the Fall term for research in the following Winter and Spring terms.  An interview with the potential faculty research mentor is part of the application process.

About John L. Zabriskie Jr. '61 (1939-2014)

This program is supported by a generous endowment from Dr. John L. Zabriskie Jr., a Dartmouth College Chemistry major in the Class of 1961.  Dr. Zabriskie conducted undergraduate research at Dartmouth with Professor Thomas Spencer, an experience that led him to continue in Chemistry as his profession.

Dr. Zabriskie received his Ph.D. in Organic Chemistry from the University of Rochester.  He was Chairman and CEO of the Upjohn Co. from 1993 to 1995, becoming only the second non-Upjohn family member to lead the pioneering pharmaceutical company during a more than 100-year span, and Chairman and CEO of Pharmacia & Upjohn, Inc. from 1995 to 1997.  Pharmacia & Upjohn later became Pharmacia Corp. and was acquired in 2003 by Pfizer, Inc.  Dr. Zabriskie served on various Boards of Directors including Array Biopharma, ARCA Biopharma, and the privately held PureTech Ventures.  He was a member of the Kellogg Co. Board of Directors from 1995 to 2013.